Biocompatibility of Novel Ferromagnetic, Nanoprobes Coupled to Bone Marrow Derived Multipotential Mesenchymal Stromal/Stem Cells for Cell Tracking in Cardiac Cell Therapy

c sidotmane,w zhou,x f zhang,teodor veres,hung q ly
DOI: https://doi.org/10.1016/j.cjca.2013.07.591
IF: 6.614
2013-01-01
Canadian Journal of Cardiology
Abstract:Ischemic heart disease (IHD) remains a leading cause of mortality worldwide. Cardiac cell therapy (CCT) has emerged as a novel therapeutic strategy to help improve cardiac repair. Bone marrow derived multipotential mesenchymal stem/stromal cells (BM-MSC) represent a promising cell population for CCT. Nevertheless, key challenges need to be addressed in order to favour appropriate clinical translation of MSC-based CCT, such as in vivo cell tracking following cell delivery.
What problem does this paper attempt to address?